Epistemonikos | Repository

Results: 1 - 10 of 1,044

Total: 1,044 recommendations

Breastfeeding women who are < 48 hours postpartum can generally use levonorgestrel-releasing Intrauterine devices (LNG-IUDs)

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Very Low

Breastfeeding women who are ≥ 6 months postpartum can use progestogen-only pills, progestogenonly injectables (depot medroxyprogesterone acetate and norethisterone enantha), and levonorgestrel and etonogestrel implants without restriction

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Low

For pregnant women, emergency contraceptive pills (ECPs) use is not applicable

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Breastfeeding women who are ≥ 48 hours to < 4 weeks postpartum should generally not have an levonorgestrel-intrauterine devices or copper-bearing intrauterine devices inserted

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Very Low

Women who are > 42 days postpartum can use combined hormonal contraceptives without restriction

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Low

Medical eligibility criteria for contraceptive use. Women who are actively breastfeeding and are ≥ 4 weeks postpartum can use the progesterone-releasing vaginal ring without restrictions

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Low

Women who are ≥ 6 weeks to < 6 months postpartum and breastfeeding can use progestogen-only pills, progestogenonly injectables (depot medroxyprogesterone acetate and norethisterone enantha), and levonorgestrel and etonogestrel implants without restriction

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Breastfeeding women who are ≥ 4 weeks postpartum can use an levonorgestrel-intrauterine devices or copper-bearing intrauterine devices without restriction

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Very Low

Women who are < 21 days postpartum and do not have other risk factors for venous thromboembolism (VTE) generally should not use combined hormonal contraceptives (MEC Category 3).

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Low

Women who are < 21 days postpartum with other risk factors for venous thromboembolism (VTE) should not use combined hormonal contraceptives (MEC Category 4).

Year: 2025

Institution: Medical eligibility criteria for contraceptive use, 6th ed.

Certainty of evidence

Low